These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 668776)

  • 1. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man.
    Neuvonen PJ; Elfving SM; Elonen E
    Eur J Clin Pharmacol; 1978 May; 13(3):213-8. PubMed ID: 668776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of activated charcoal on aspirin absorption in man. Part I.
    Levy G; Tsuchiya T
    Clin Pharmacol Ther; 1972; 13(3):317-22. PubMed ID: 5026372
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption.
    Juhl RP
    Am J Hosp Pharm; 1979 Aug; 36(8):1097-8. PubMed ID: 484570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by ice cream of the antidotal efficacy of activated charcoal.
    Levy G; Soda DM; Lampman TA
    Am J Hosp Pharm; 1975 Mar; 32(3):289-91. PubMed ID: 1136978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated charcoal-carboxymethylcellulose gel formulation as an antidotal agent for orally ingested aspirin.
    Mathur LK; Jaffe JM; Colaizzi JL; Moriarty RW
    Am J Hosp Pharm; 1976 Jul; 33(7):717-9. PubMed ID: 941924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans.
    Easom JM; Caraccio TR; Lovejoy FH
    Clin Pharm; 1982; 1(2):154-6. PubMed ID: 7185512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide.
    Neuvonen PJ; Kivistö K; Hirvisalo EL
    Br J Clin Pharmacol; 1988 Feb; 25(2):229-33. PubMed ID: 3358884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of aspirin absorption by activated charcoal and apomorphine.
    Decker WJ; Shpall RA; Corby DG; Combs HF; Payne CE
    Clin Pharmacol Ther; 1969; 10(5):710-3. PubMed ID: 5808464
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of ethanol and pH on the adsorption of drugs to activated charcoal: studies in vitro and in man.
    Neuvonen PJ; Olkkola KT; Alanen T
    Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):1-7. PubMed ID: 6702463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between effect of activated charcoal on drug absorption in man and its drug adsorption characteristics in vitro.
    Tsuchiya T; Levy G
    J Pharm Sci; 1972 Apr; 61(4):586-9. PubMed ID: 5014316
    [No Abstract]   [Full Text] [Related]  

  • 11. Do gastric contents modify antidotal efficacy of oral activated charcoal?
    Olkkola KT; Neuvonen PJ
    Br J Clin Pharmacol; 1984 Nov; 18(5):663-9. PubMed ID: 6508975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose.
    Curtis RA; Barone J; Giacona N
    Arch Intern Med; 1984 Jan; 144(1):48-52. PubMed ID: 6140906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of administration of activated charcoal and fibre on absorption, excretion and steady state blood levels of digoxin and digitoxin. Evidence for intestinal secretion of the glycosides.
    Reissell P; Manninen V
    Acta Med Scand Suppl; 1982; 668():88-90. PubMed ID: 6963097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of five activated charcoal formulations for inhibition of aspirin absorption and palatability in man.
    Scholtz EC; Jaffe JM; Colaizzi JL
    Am J Hosp Pharm; 1978 Nov; 35(11):1355-9. PubMed ID: 707504
    [No Abstract]   [Full Text] [Related]  

  • 15. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs.
    Lapatto-Reiniluoto O; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2001 Sep; 70(3):255-60. PubMed ID: 11557913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of delayed administration of activated charcoal on nortriptyline absorption.
    Dawling S; Crome P; Braithwaite R
    Eur J Clin Pharmacol; 1978 Dec; 14(6):445-7. PubMed ID: 738352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil.
    Laine K; Kivistö KT; Neuvonen PJ
    J Toxicol Clin Toxicol; 1997; 35(3):263-8. PubMed ID: 9140320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of activated charcoal on absorption of tolbutamide and valproate in man.
    Neuvonen PJ; Kannisto H; Hirvisalo EL
    Eur J Clin Pharmacol; 1983; 24(2):243-6. PubMed ID: 6404636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large surface area activated charcoal and the inhibition of aspirin absorption.
    Dillon EC; Wilton JH; Barlow JC; Watson WA
    Ann Emerg Med; 1989 May; 18(5):547-52. PubMed ID: 2719366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of "thickening" agents on the antidotal efficacy of activated charcoal.
    Gwilt PR; Perrier D
    Clin Toxicol; 1976; 9(1):89-92. PubMed ID: 1277772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.